-
RTI Biologics and STAAR Surgical End the Week Near 52-Week Highs
Saturday, August 20, 2011 - 11:37am | 541Read More...The markets ended the week closing lower two days in a row. Yet small cap biotech companies RTI Biologics (NASDAQ: RTIX) and STAAR Surgical (NASDAQ: STAA) rose to new 52-week highs of $3.75 and $7.08 per share, respectively, in Friday's trading session. RTI Biologics has been in a very strong...
-
Benchmark Reports STAAR Surgical's Q4 Revenue Beat Eclipsed by Accelerating Spending but 2011 Continues to Look Promising
Wednesday, March 2, 2011 - 9:21am | 154Read More...According to Benchmark, STAAR Surgical Corporation's (NASDAQ: STAA) Q4 revenue was eclipsed by accelerating spending but 2011 continues to look promising. Benchmark reported that revenue in 4Q10 expanded 8.3% to $14.4 million, which exceeded the $14.2 million consensus and Benchmark forecast. “Loss...
-
STAA Initiated At Buy
Tuesday, October 12, 2010 - 10:26am | 15Read More...Morgan Joseph has initiated coverage on STAAR Surgical Company at Buy with a $6.40 price target.
